DFA Team

DFA is led by a national steering committee, combining expertise from multiple disciplines. The committee is comprised of a broad range of clinical, research and industry experts from disciplines such as endocrinology, vascular surgery, podiatry, nursing, epidemiology, clinical research and biochemical research. Members also bring a wealth of experience by being representatives on international, national and state diabetic foot groups, including the ‘International Working Group on the Diabetic Foot’ and former national diabetic foot ulcer group the ‘Australian Diabetic Foot Network’.

Mr Peter Lazzarini image

Dr Peter Lazzarini

Co-Chair, DFA Steering Committee

Pete is Senior Research Fellow in the Foot Disease Research program at QUT and Qld Health.  He was a founding member of the Australian Diabetic Foot Network, NHMRC Diabetes Update Guidelines and Queensland Diabetes Network steering committees.  Pete has also been vice-president of the Australasian Podiatry Council Board and Chair of the Australasian Podiatry Conference.  He has vast experience managing large state-wide diabetes projects that have resulted in state-wide reductions in diabetes hospitalisations and amputations.   For the past four years he has worked in a conjoint research role completing his PhD and building Australia’s first Foot Disease Research program with the goal of ending avoidable amputations.  This has resulted in 40+ published journal papers, $900,000+ in grants, 3 higher degree research students and 4 international collaborations.

A/Professor Paul Wraight

A/Professor Paul Wraight

Co-Chair, DFA Steering Committee

Paul is clinical associate professor of The University of Melbourne and Endocrinologist at The Royal Melbourne Hospital.  Paul is one of two Australian representatives on the International Working Group of the Diabetic Foot, was founding chair of the Australian Diabetic Foot Network and NHMRC Diabetes Update Guidelines member.  He completed his PhD in 2005 into “Improving clinical outcomes for patients with diabetes related foot complications” and is Director of the Diabetic Foot Unit at RMH.  He continues to undertake clinical research into the diabetic foot with current NHMRC and Victorian government grants and has 20 peer reviewed publications and 2 book chapters.

Dr Jenny Prentice

Dr Jenny Prentice

DFA Steering Committee Member

Jenny’s clinical background encompasses over 35 years’ experience in wound management, palliative care, acute gastro-intestinal surgery, nursing administration, project management and nursing consultancy nationally and internationally within acute, domiciliary/community and residential aged care settings. Jenny contributed to the establishment of WoundsWest, a tripartite entity between Western Australian Department of Health, Silver Chain and Curtin University in 2006 assuming the role of Director in December 2008. WoundsWest, provided a sustainable framework for improving wound management in Western Australian through clinical audits, online wound education and an e-health wound consultation service. Jenny is now Chief Executive Officer of Wound Healing Institute Australia (WHIA), a new company formed as a realisation of the vision and investment of the WoundsWest Program. Jenny has extensive experience in wound research and has peer reviewed NH&MRC and other wound related grant applications. Jenny has participated in several WMIC CRC research projects and committees, including Diabetic Foot Australia and the Australian Wound Registry. She enjoys supervising higher degree student’s research in wound management and delivering wound education programs particularly within Indigenous communities.

Ewan Kinnear

Mr Ewan Kinnear

DFA Steering Committee Member

Ewan Kinnear is the Director of Allied Health at The Prince Charles Hospital, Metro North Hospital and Health Service (MNHHS) and chair of the Queensland Diabetes Foot Working Group (DFWG).  He is also an active committee member on the Statewide Diabetes Clinical Network. His professional interests include Diabetes, High Risk Foot Care, lower extremity Pressure Injury and Wound Management.

As District Director of Podiatry, MNHHS, 2007 to 2014, he has strategically managed the development and advancement of ‘High Risk Foot’ Podiatry Services across MNHHS.  Empowering his ‘team’ he has led the development and introduction of Foot Health eligibility criteria and Core Business Statements within Metro North Hospital and Health Service. These foundation documents have since been adopted throughout Qld Health and considered in other states.

Ewan’s commitment and innovative approach to the advancement of podiatric medicine through evidence based practice and research has facilitated the research program that we are so proud off today.

Professor Robert Fitridge

Professor Robert Fitridge

DFA Steering Committee Member

Rob is Professor of Vascular Surgery at the University of Adelaide and Head of Vascular Surgery at The Queen Elizabeth Hospital. He is one of two Australian representatives on the International Working Group on the Diabetic Foot and co-chair of the Sydney International Diabetic Foot Conference.  Rob is also a steering committee member on the Global Vascular Guidelines and past Chair of the Board of Vascular Surgery of the Royal Australasian College of Surgeons leading the development of the formal vascular curriculum.  He also established the Diabetic Foot services at the Queen Elizabeth Hospital, the Royal Adelaide Hospital and Lyell McEwin Health Service. He is currently a Chief Investigator on 4 NHMRC grants and has published widely including editing the Oxford Textbook of Vascular Surgery.

.

Byron Perrin

Dr Byron Perrin

DFA Steering Committee Member

Byron is currently Head of Department of Community and Allied Health, La Trobe Rural Health School. He also functions as the Senior Lecturer of the podiatry course delivered from the La Trobe Rural Health School.

Mr Matthew Malone

Mr Matthew Malone

DFA Steering Committee Member

Matthew is Director of the Department of Podiatric Medicine at Liverpool Hospital in Sydney.  He is founder and co-chair of the Sydney International Diabetic Foot Conference, founding member of the Liverpool Diabetes Collaborative Research Unit and vice-president of the national Advanced Practicing Podiatrist – High Risk Foot Group.  Matthew has worked in diabetes limb salvage units in the UK (under Professor Andrew Boulton widely regarded as the ‘world’s expert’ on the diabetic foot), Saudi Arabia and Australia.  He has published widely in the area of diabetic foot disease and is currently undertaking his PhD using advanced molecular and microscopy techniques to determine what bacteria reside in diabetic foot ulcers.  Matthew’s expertise was recently awarded a fellowship to the Royal College of Physicians and Surgeons of Glasgow.

Ian Griffiths

Dr Ian Griffiths

DFA Steering Committee Member

Dr Ian Griffiths is currently the Chief Executive Officer of the Wound Management Innovation Cooperative Research Centre (WMI CRC). Ian was previously the CEO of AorTech Pty Ltd, COO of AorTech Biomaterials plc, CEO of PolyNovo Pty Ltd and CEO of Novoskin Pty.  Ian has worked for more than 17 years in commercialising innovative medical devices including wound management products.  In addition, Ian has served on a number of public and private company boards. Dr Griffiths has an MBA, a PhD from the University of Manchester with his thesis based on instrumentation physics and polymer chemistry. Dr Griffiths has been a guest speaker at numerous public events, conferences and investment forums and has a distinguished academic publication list.  He has an extensive background in business development, licensing & acquisitions, medical technology commercialisation, capital raising and critical stakeholder management.

Jaap van Netten

Dr Jaap van Netten

Scientific Director

Jaap van Netten is a human movement scientist from the Netherlands, specialized in clinical research on foot problems, most notably in people with diabetes. Two years after his graduation, he obtained his PhD in the field of rehabilitation medicine (University Medical Center Groningen, NL), studying people’s use of custom-made orthopaedic shoes. He continued working as postdoc researcher in ZGT ([Hospital Group Twente], Almelo and Hengelo, NL), joining the diabetic foot team. He developed to a senior researcher position, supervising projects in the three research lines of the diabetic foot team. Next to this, he was head of the Scientific Bureau of ZGT.

Early 2016, Van Netten moved to Australia, to continue to build a strong link between research and clinical practice, but on the other side of the world. He is appointed Senior Research Fellow at the Queensland University of Technology, and Scientific Director of Diabetic Foot Australia. His scientific work has so far resulted in 50+ publications and obtaining >1.5 million dollar in research funding.

Van Netten is also the secretary of the International Working Group on the Diabetic Foot Editorial Board and its Prevention Working Group. In these roles he is co-authoring the evidence-based international consensus guidance on the prevention and management of foot problems in diabetes. The latest version of this guidance has been launched in May 2015 during the International Diabetic Foot Symposium in The Hague; the road to the next update in 2019 has already started.

Sharif Sethi

Mr Sharif Sethi

DFA Chief Operating Officer

Mr Sharif Sethi leads Diabetic Foot Australia’s national office team. He brings with him more than 25 years of experience in business operations including pharmaceutical sales & marketing, product development & launch and commercial operations. Sharif’s experience in new business strategy, product innovation, complex project programs and management of both people and business operations has consistently driven growth in market share and profitability. His cross-functional business development and management abilities, gained in both local and international markets, have proven invaluable to the planning, development and roll out of Diabetic Foot Australia (DFA) as a national peak body. DFA advocates best practice multi-disciplinary care for patients in the fight against Diabetic Foot Disease. In addition to decades of operational experience, Sharif is degree-qualified in Science (Microbiology & Chemistry) with further education in Business Administration management including project & financial management and people leadership.

Shelley Morris DFA Communications Manager

Shelley Morris

DFA Branding & Communications Manager

Shelley Morris is part of Diabetic Foot Australia’s national office team. As the Communications Manager she oversees internal & external communications, marketing, design and brand management. Shelley commenced with the Wound Management Innovation CRC in February 2012 and currently oversees the communications, marketing, design and brand management of all areas of the WMI CRC’s activities. Shelley’s background and qualifications are in graphic design, web design, marketing, events, business administration, accounting and human resources.

Cecile Francis

Cecile Francis

DFA Clinical Trials Manager

Cecile Francis is providing support to the Diabetic Foot Australia’s national office team for the coordination of clinical trials and the development of a national trial network. She is a highly motivated and dynamic Clinical Research Manager providing invaluable advice to our cross-functional team. With a well-honed capability in clinical research management across a broad range of organisations (pharmaceutical industry, non for profit and public health service), Cecile’s multinational experience is an enormous asset to clients of the DFA clinical trials network.